Increased MCL-1 Expression Is Associated with Poor Prognosis in Ovarian Carcinomas-Reference-Cited by-同舟云学术

Increased MCL-1 Expression Is Associated with Poor Prognosis in Ovarian Carcinomas

Published:2002-05 Issue:5 Volume:93 Page:542-550
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Shigemasa Kazushi,Katoh Osamu,Shiroyama Yuko,Mihara Shoji,Mukai Keiji,Nagai Nobutaka,Ohama Koso

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2002.tb01289.x/fullpdf

Reference32 articles.

1. Cancer statistics;Parker;CA Cancer J. Clin.,1996

2. The proto-oncogene Bcl-2 and its role in regulating apoptosis;Kroemer;Nat. Med.,1997

3. BCL-2 gene family and the regulation of programmed cell death;Korsmeyer;Cancer Res.,1999

4. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer;McDonnell;Cancer Res.,1992

5. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy;Campos;Blood,1993

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors;PLOS ONE;2024-07-16

2. Modeling the Binding of Anticancer Peptides and Mcl-1;International Journal of Molecular Sciences;2024-06-13

3. Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options;Cells;2024-05-04

4. Amplified therapeutic targets in high-grade serous ovarian carcinoma – a review of the literature with quantitative appraisal;Cancer Gene Therapy;2023-02-20

5. Synergistic combination therapy delivered via layer‐by‐layer nanoparticles induces solid tumor regression of ovarian cancer;Bioengineering & Translational Medicine;2022-11-08